CORZ - Core Scientific, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.60
DETAILS
HIGH:
$37.00
LOW:
$29.00
MEDIAN:
$30.00
CONSENSUS:
$31.60
UPSIDE:
25.10%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 11.9% |
| EBIT Margin | -70.4% |
| EBITDA Margin | -45.3% |
| Operating Margin | -70.4% |
| Pretax Margin | -90.3% |
| Cont. Ops Margin | -90.5% |
| Net Margin | -90.5% |
| Bottom Line Margin | -90.5% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 1.15 |
| Quick Ratio | 1.15 |
| Solvency Ratio | -0.063 |
| Cash Ratio | 0.40 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.19 |
| Forward PEG | 0.19 |
| Price/Book | -4.81 |
| Price/Sales | 14.52 |
| Price/FCF | -10.27 |
| Price/Op Cash Flow | 16.64 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.4517 |
| Debt/Equity | -1.1014 |
| Debt/Capital | 10.8657 |
| Long-Term Debt/Capital | 10.8657 |
| Financial Leverage | -2.44 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.72 |
| Operating Cash Flow Ratio | 0.356 |
| Operating Cash Flow/Sales | 87.2% |
| Free Cash Flow/Operating Cash Flow | -162.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | 0.26 |
| Capital Expenditure Coverage | 0.38 |
| Dividend + Capital Expenditure Coverage | 0.38 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.00 |
| EPS | -0.907 |
| Debt/Share | 3.3336 |
| Cash/Share | 0.98 |
| Book Value/Share | -3.03 |
| Tangible BV/Share | -3.03 |
| Equity/Share | -3.03 |
| Operating Cash Flow/Share | 0.875 |
| Capital Expenditure/Share | 2.292 |
| FCF/Share | -1.417 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.002 |
| Earnings Before Tax/EBIT | 1.283 |
| Price/Fair Value | -4.81 |
| Debt/Market Cap | 0.2290 |
| Effective Tax Rate | -0.2% |
| Enterprise Value Multiple | -37.27 |